当前位置:首页 - 行情中心 - 汉森制药(002412) - 财务分析

汉森制药

(002412)

  

流通市值:27.12亿  总市值:27.73亿
流通股本:4.92亿   总股本:5.03亿

汉森制药(002412)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.10亿元,每股收益0.22元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益186419.09万元,未分配利润96240.50万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产226973.97万元,负债40554.88万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入684,141,818.56471,672,377.47250,177,963.58916,062,371.53
营业总成本615,700,129.45415,119,114.14202,676,986.6785,785,445.99
营业利润116,964,664.5100,118,363.5962,712,289.46188,790,756.2
利润总额117,089,083100,147,577.2162,790,173.27181,852,534.15
净利润109,742,317.4590,667,175.7455,067,482.18167,615,535.76
其他综合收益11,276,904.911,468,251.745,591,418.07-17,126,362.65
综合收益总额121,019,222.35102,135,427.4860,658,900.25150,489,173.11
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计830,305,842.99816,525,600.44933,341,824.23865,402,215.15
非流动资产合计1,439,433,848.911,462,152,651.971,435,281,442.021,425,541,834.9
资产总计2,269,739,691.92,278,678,252.412,368,623,266.252,290,944,050.05
流动负债合计387,985,205.99415,191,325.63394,985,116.66380,237,155.69
非流动负债合计17,563,560.6418,179,796.3818,847,546.4216,575,191.44
负债合计405,548,766.63433,371,122.01413,832,663.08396,812,347.13
归属于母公司股东权益合计1,864,190,925.271,845,307,130.41,954,790,603.171,894,131,702.92
股东权益合计1,864,190,925.271,845,307,130.41,954,790,603.171,894,131,702.92
负债和股东权益合计2,269,739,691.92,278,678,252.412,368,623,266.252,290,944,050.05
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计784,850,845.91538,773,212.26294,293,986.891,001,514,573.57
经营活动现金流出小计675,472,088.69464,083,234.23223,846,874.4857,708,326.05
经营活动产生的现金流量净额109,378,757.2274,689,978.0370,447,112.49143,806,247.52
投资活动现金流入小计795,118,314.05557,593,083.92160,950,579.91338,605,557.76
投资活动现金流出小计793,379,979.91517,708,377.5234,895,410.62423,099,225.49
投资活动产生的现金流量净额1,738,334.1439,884,706.42-73,944,830.71-84,493,667.73
筹资活动现金流入小计103,094,444.4883,094,444.483,048,417.57151,553,010.3
筹资活动现金流出小计284,016,501.06223,979,667.611,002,500.02165,771,421.87
筹资活动产生的现金流量净额-180,922,056.58-140,885,223.132,045,917.55-14,218,411.57
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-69,804,965.22-26,310,538.68-1,451,800.6745,094,168.22
期末现金及现金等价物余额65,600,648.7109,095,075.24143,953,813.25135,405,613.92
TOP↑